EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GPCR: Structure Therapeutics Inc

28 Oct 25 12:56
LAST:

28.55

CHANGE:
 0.11		OPEN:
28.65		HIGH:
29.40		ASK:
0.00		VOLUME:
123.1K
CHG(%):
0.37		PREV:
28.65		LOW:
28.22		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Oct 2528.6529.4028.2228.55123.1K
27 Oct 2526.7428.8226.6228.65704.8K
24 Oct 2526.6026.7825.9426.39770.3K
23 Oct 2526.8527.4925.8626.56722.2K
22 Oct 2526.7627.0025.5926.66947.7K
21 Oct 2527.8728.2426.6726.92457.9K
20 Oct 2527.8728.2627.4027.87662.8K
17 Oct 2527.0628.5627.0027.38510.8K
16 Oct 2529.3729.6627.4927.561.01M
15 Oct 2530.3831.0829.2129.231.54M

COMPANY PROFILE

Name:Structure Therapeutics Inc
About:Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671, which is in preclinical trial to treat obesity; ANPA-0073, an oral small molecule agonist targeting the apelin, which is phase 2 ready for selective weight loss or muscle-sparing weight loss; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Website:https://structuretx.com
CIK:0001888886
ISIN:US86366E1064
FIGI:BBG01CBVHLW1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:27.364.3%
MA10:27.583.5%
MA20:28.111.5%
MA50:24.1518.2%
MA100:21.8230.8%
MA200:22.5126.8%
STO9:65.90
STO14:45.95
RSI14:50.48
WPR14:-48.20
MTM14:-2.01
ROC14:-0.07 
ATR:1.60 
Week High:29.403.0%
Week Low:25.5911.5%
Month High:31.088.9%
Month Low:24.6326.8%
Year High:42.5749.1%
Year Low:13.22115.9%